BDBM518587 US11124523, Example (+)-23

SMILES Fc1ccc(nc1)[C@]1(CCNCc2cccc(F)c2)CCO[C@]2(CCOC2)C1

InChI Key InChIKey=VMXUKMKIISVLGY-UHFFFAOYSA-N

Data  5 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 518587   

TargetMu-type opioid receptor(Human)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataEC50:  1nMAssay Description:The experiment was performed using a cAMP detection kit from Cisbio (Cisbio #62AM4PEJ).More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataIC50: 1.78E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetCytochrome P450 1A2(Rat)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataIC50: 5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataIC50: 5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetCytochrome P450 2C19(Human)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataIC50: 5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
TBA

US Patent
LigandPNGBDBM518587(US11124523, Example (+)-23)
Affinity DataIC50: 5.00E+4nMAssay Description:To test the inhibitory effects of the compounds of the present disclosure on different isoforms of human cytochrome P450 isoenzymesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent